Menu
Ken MacLeod
Partner
Kenneth Macleod joined Rosetta Capital in 2021 as a Partner. Ken has over 35 years experience in the life sciences sector through senior operating roles in healthcare companies (Abbott Labs., Serono) and life science fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners).
Ken currently holds board positions at JenaValve Technologies, inc. and Oxular Limited and has previously held board roles at Pharming Group N.V., SpePharm Holding B.V. and On-X Life Technologies, Inc.
Ken received a BSc in Biological Sciences from the University of Manchester and a D.Phil from the University of York.
Ken received a BSc in Biological Sciences from the University of Manchester and a D.Phil from the University of York.
Meet more of our people
